Call Options

9 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$5.29 - $7.77 $422,671 - $620,823
79,900 Added 20.02%
479,100 $2.8 Million
Q2 2024

Aug 14, 2024

BUY
$7.1 - $11.03 $132,060 - $205,158
18,600 Added 4.89%
399,200 $2.93 Million
Q1 2024

May 15, 2024

SELL
$5.9 - $10.3 $225,380 - $393,460
-38,200 Reduced 9.12%
380,600 $2.77 Million
Q4 2023

Feb 14, 2024

BUY
$9.2 - $29.48 $1.24 Million - $3.98 Million
134,900 Added 47.52%
418,800 $4.06 Million
Q3 2023

Nov 14, 2023

BUY
$13.11 - $21.68 $945,231 - $1.56 Million
72,100 Added 34.04%
283,900 $5.85 Million
Q2 2023

Aug 14, 2023

BUY
$11.41 - $21.44 $281,827 - $529,568
24,700 Added 13.2%
211,800 $3.04 Million
Q1 2023

May 15, 2023

SELL
$12.42 - $23.37 $1.64 Million - $3.08 Million
-131,700 Reduced 41.31%
187,100 $3.86 Million
Q4 2022

Feb 14, 2023

BUY
$16.5 - $25.25 $1.85 Million - $2.83 Million
112,200 Added 54.31%
318,800 $5.5 Million
Q3 2022

Nov 14, 2022

SELL
$15.83 - $35.31 $15,830 - $35,310
-1,000 Reduced 0.48%
206,600 $4.95 Million

Others Institutions Holding LABD

About DIREXION DAILY S&P BIOTECH BEA


  • Ticker LABD
  • Sector ETFs
  • Industry ETFs
More about LABD
Track Ken Griffin's Portfolio

Track Ken Griffin Portfolio

Follow Ken Griffin (Citadel Advisors LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.